Results for tag: "Rimonabant"

Rimonabant is a drug used to treat obesity, which works by blocking the CB1 receptor in the brain. It is a selective cannabinoid receptor antagonist, meaning it blocks the action of the endocannabinoid system, which is involved in the regulation of appetite and metabolism. Rimonabant is the first drug of its kind to be approved for use in the treatment of obesity. It is also used to treat metabolic syndrome, a condition characterized by high blood pressure, high cholesterol, and insulin resistance. Rimonabant has been available in Europe since 2006, but was withdrawn from the market in 2008 due to safety concerns. Despite this, it remains a popular choice for treating obesity and metabolic syndrome in many countries. Companies in the Rimonabant market include Sanofi, Pfizer, Merck, and Novartis. Show Less Read more